Intellectual property organizations

DSS’s Impact BioMedical Receives Notice of Allowance from USPTO for Equivir Patent

Retrieved on: 
Tuesday, April 6, 2021
Intellectual property law, Intellectual property organizations, United States Patent and Trademark Office, United States trademark law, Patent

This allowance is in addition to Equivirs previously issued U.S. patent in influenza.

Key Points: 
  • This allowance is in addition to Equivirs previously issued U.S. patent in influenza.
  • This was one of our pending patents for Equivir, and we are very pleased to have expanded our Impact BioMedical intellectual property estate with this allowance, stated Frank D. Heuszel, CEO of DSS.
  • Impact BioMedical received its first Equivir patent (US 10,383,842) from the USPTO on August 20, 2019.
  • Impact BioMedical, Inc. ("Impact BioMedical") is a wholly owned subsidiary of DSS and a unique technology source, developer, and business partner in addressing unmet needs in human healthcare and wellness.

International Trademark Association Board Adopts Resolutions to Strengthen Anticounterfeiting Enforcement

Retrieved on: 
Friday, March 19, 2021
Intellectual property organizations, International Trademark Association, Forgery, INTA, Counterfeit

NEW YORK, March 19, 2021 /PRNewswire-PRWeb/ -- Bolstering its efforts to fight the proliferation of counterfeiting worldwide, the Board of Directors of the International Trademark Association (INTA) today approved two resolutions calling on courts and policymakers to implement new mechanisms to strengthen anticounterfeiting enforcement and disrupt these illegal activities across the globe.

Key Points: 
  • NEW YORK, March 19, 2021 /PRNewswire-PRWeb/ -- Bolstering its efforts to fight the proliferation of counterfeiting worldwide, the Board of Directors of the International Trademark Association (INTA) today approved two resolutions calling on courts and policymakers to implement new mechanisms to strengthen anticounterfeiting enforcement and disrupt these illegal activities across the globe.
  • The resolutions expand the Association's anticounterfeiting policies to cover two additional advocacy points: "Proceeds of Counterfeiting" and "Remarking as Criminal Counterfeiting."
  • Their adoption allows the Association and its Anticounterfeiting Committee, which drafted the resolutions, to advocate for these critical measures aimed at protecting brand owners and consumers in jurisdictions worldwide.
  • The Board has previously adopted anticounterfeiting resolutions, including the last one in 2019 on the "Appointment of Third-Party Witnesses in Judicial Anticounterfeiting Cases."

Voleo Announces Receipt of United States Patent

Retrieved on: 
Friday, March 12, 2021
Intellectual property law, Finance, Money, Financial technology, Voleo, Patent offices, Intellectual property organizations, United States Patent and Trademark Office, Patent and Trademark Office, United States patent law, Patent

Vancouver, British Columbia--(Newsfile Corp. - March 12, 2021) - Voleo Trading Systems Inc. (TSXV: TRAD) ("Voleo") is pleased to announce the receipt of United States Patent 10,937,098 for the United States Patent and Trademark Office (USPTO) for patent claims covering certain aspects of Voleo's technology.

Key Points: 
  • Vancouver, British Columbia--(Newsfile Corp. - March 12, 2021) - Voleo Trading Systems Inc. (TSXV: TRAD) ("Voleo") is pleased to announce the receipt of United States Patent 10,937,098 for the United States Patent and Trademark Office (USPTO) for patent claims covering certain aspects of Voleo's technology.
  • Voleo's technology platform remains operational and a complete technical analysis of Voleo's software ecosystem has been undertaken.
  • Voleo's intellectual property is secure and can be quickly deployed into a fresh, new environment.
  • Voleo also announces that it has issued a total of 1,425,000 stock options to directors, officers and consultants, with the stock options exercisable at $0.25 for a five-year period.

Fido Announces Filing of US Patent Application for Credit Scoring System and Method with Digital Footprints

Retrieved on: 
Wednesday, March 10, 2021
Intellectual property law, Personal finance, Intellectual property organizations, United States patent law, United States Patent and Trademark Office, United States trademark law, Procyclical and countercyclical variables, Credit score in the United States, Credit score, Patent and Trademark Office, Provisional application

MILAN, March 10, 2021 /PRNewswire/ -- Fido today announced that it has filed a nonprovisional patent application with the United States Patent and Trademark Office (USPTO) for providing a new credit score system and method with digital footprints.

Key Points: 
  • MILAN, March 10, 2021 /PRNewswire/ -- Fido today announced that it has filed a nonprovisional patent application with the United States Patent and Trademark Office (USPTO) for providing a new credit score system and method with digital footprints.
  • Credit scoring using so-called hard information (income, employment time, assets and debts) is nothing new.
  • First, hard information tends to be "procyclical": it boosts credit expansion in good times but exacerbates contraction during downturns.
  • The service is functional to companies of any size (consumer credit companies, digital retailers, small start ups).

Fido Announces Filing of US Patent Application for Credit Scoring System and Method with Digital Footprints

Retrieved on: 
Wednesday, March 10, 2021
Intellectual property law, Personal finance, Intellectual property organizations, United States patent law, United States Patent and Trademark Office, United States trademark law, Procyclical and countercyclical variables, Credit score in the United States, Credit score, Patent and Trademark Office, Provisional application

MILAN, March 10, 2021 /PRNewswire/ -- Fido today announced that it has filed a nonprovisional patent application with the United States Patent and Trademark Office (USPTO) for providing a new credit score system and method with digital footprints.

Key Points: 
  • MILAN, March 10, 2021 /PRNewswire/ -- Fido today announced that it has filed a nonprovisional patent application with the United States Patent and Trademark Office (USPTO) for providing a new credit score system and method with digital footprints.
  • Credit scoring using so-called hard information (income, employment time, assets and debts) is nothing new.
  • First, hard information tends to be "procyclical": it boosts credit expansion in good times but exacerbates contraction during downturns.
  • The service is functional to companies of any size (consumer credit companies, digital retailers, small start ups).

Annovis Bio Receives Japanese Patent for the Treatment of Acute Brain or Nerve Injury

Retrieved on: 
Wednesday, March 10, 2021
Intellectual property law, Patent offices, Patent law, International Searching and Preliminary Examining Authorities, European Patent Organisation, Intellectual property organizations, European Patent Office, United States Patent and Trademark Office, Patent office, Patent

"This new patent further strengthens our intellectual property focused on the treatment of neurodegenerative diseases," commented Maria Maccecchini, Ph.D., CEO of Annovis.

Key Points: 
  • "This new patent further strengthens our intellectual property focused on the treatment of neurodegenerative diseases," commented Maria Maccecchini, Ph.D., CEO of Annovis.
  • "We believe there are additional opportunities to expand our patent coverage both globally and in the US.
  • The Company received its first PD patent (US 10,383,851) from the USPTO in August 2019 and its first AD patent (EP 2683242) from the European Patent Office (EPO) in March 2020.
  • The EPO approved Annovis Bio's first acute patent (EP 3334425B1) in December 2020.

IGC Receives Another Patent for a Cannabinoid-Based Cream for Treating Pain

Retrieved on: 
Monday, March 8, 2021
Pharmaceutical, Health, Other Health, Intellectual property law, Intellectual property organizations, United States Patent and Trademark Office, United States trademark law, Patent application, Patent

The patent application was filed on October 1, 2018.

Key Points: 
  • The patent application was filed on October 1, 2018.
  • The latest patent approval adds to the Companys existing patent portfolio, which includes patent issuances by the USPTO for seizure disorders and eating disorders.
  • IGC operates two lines of business: (i) infrastructure and (ii) life sciences.
  • The Company is based in Potomac, Maryland, U.S.A. social media: www.igcinc.us , www.igcpharma.com , Twitter @IGCIR.

GeoVax Expands and Strengthens Intellectual Property Portfolio

Retrieved on: 
Thursday, March 4, 2021
Monopoly, Patent law, Patent portfolio, Patent, Intellectual property organizations

Cancer vaccination is the subject of growing interest as a means to boost the bodys innate defense to cancer.

Key Points: 
  • Cancer vaccination is the subject of growing interest as a means to boost the bodys innate defense to cancer.
  • David Dodd, GeoVaxs Chairman & CEO, commented, These patent filings reflect our continued progress in advancing high-value development programs while seeking the strongest intellectual property portfolio possible.
  • With these filings, our wholly owned, co-owned, and in-licensed intellectual property portfolio now stands at over 70 granted or pending patent applications spread over 20 patent families.
  • We look forward to further advancing our programs and continued growth in GeoVax value.

DGAP-News: Virpax(R) Pharmaceuticals Inc.: Virpax Pharmaceuticals Announces Newly Issued Patent for Probudur(TM)

Retrieved on: 
Tuesday, March 2, 2021
Intellectual property law, Monopoly, Patent law, Intellectual property organizations, Patent, United States patent law, United States Patent and Trademark Office, Pharmaceutical industry in China, Outline of patents

WEST CHESTER, PA, March 2, 2021 - Virpax(R) Pharmaceuticals Inc. ("Virpax" or the "Company") (NASDAQ:VRPX), a company specializing in developing pharmaceutical products for pain management, today announced that the United States Patent and Trademark Office issued US Patent No.

Key Points: 
  • WEST CHESTER, PA, March 2, 2021 - Virpax(R) Pharmaceuticals Inc. ("Virpax" or the "Company") (NASDAQ:VRPX), a company specializing in developing pharmaceutical products for pain management, today announced that the United States Patent and Trademark Office issued US Patent No.
  • This newly issued patent, which is owned by LipoCure Rx and exclusively licensed to Virpax, has 18 claims and expires in 2029.
  • "We are extremely pleased with the continued development of the patent portfolio for ProbudurTM, our long-acting anesthetic for postoperative pain management.
  • This newly issued patent further broadens our overall intellectual property portfolio," stated Anthony Mack, Chairman and CEO of Virpax.

Fuze Optimizes Call Quality with New Patent for Predicting Connectivity Issues to Improve User Experience

Retrieved on: 
Thursday, February 25, 2021
Consumer electronics, Technology, Other Technology, Telecommunications, Software, Networks, Audio, Video, Internet, VoIP, Mobile, Wireless, Hardware, Intellectual property law, Intellectual property organizations, United States Patent and Trademark Office, United States trademark law, Fuze, Telecommunications, Patent

By using machine-learning techniques to predict and resolve connectivity issues based on user data, including location and hardware, the new patent improves the user experience on the Fuze platform.

Key Points: 
  • By using machine-learning techniques to predict and resolve connectivity issues based on user data, including location and hardware, the new patent improves the user experience on the Fuze platform.
  • The U.S. Patent and Trademark Office (USPTO) issued Fuze U.S. Patent No.
  • This invention spots connectivity issues in real-time to improve user call quality by leveraging historical user experience data.
  • At Fuze, we know that the enterprise cant afford downtime due to connectivity, which is why were committed to innovations that improve call quality and proactively resolve issues before they happen.